Cargando…

The Value of Multimodality PET/CT Imaging in Detecting Prostate Cancer Biochemical Recurrence

Prostate cancer (PCa) induced death is the predominant cause of cancer-related death among men in 48 countries. After radical treatment, biochemical recurrence has become an important factor for prognosis. The early detection and diagnosis of recurrent lesions are very helpful in guiding treatment a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Jie, Tang, Xiaoxia, Pu, Yongzhu, Yang, Yong, Yang, Conghui, Yang, Fake, Tian, Yadong, Li, Jindan, Sun, Hua, Zhao, Sheng, Chen, Long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197252/ https://www.ncbi.nlm.nih.gov/pubmed/35712249 http://dx.doi.org/10.3389/fendo.2022.897513

Ejemplares similares

FAPI-PET/CT in Cancer Imaging: A Potential Novel Molecule of the Century
por: Huang, Rong, et al.
Publicado: (2022)

The progress of PET/MRI in clinical management of patients with pancreatic malignant lesions
por: Li, Jindan, et al.
Publicado: (2023)

The value of AI in the Diagnosis, Treatment, and Prognosis of Malignant Lung Cancer
por: Wang, Yue, et al.
Publicado: (2022)

The clinical application of (18)F-FDG PET/CT in pancreatic cancer: a narrative review
por: Pu, Yongzhu, et al.
Publicado: (2021)

Role of 18F-fluorodeoxyglucose PET/computed tomography in the diagnosis and treatment response assessment of primary bone lymphoma
por: Pu, Yongzhu, et al.
Publicado: (2023)

The value of (68)Ga-PSMA enhanced PET-CT and MR-PET in patients with biochemical recurrent prostate cancer
por: Rummeny, E, et al.
Publicado: (2015)

CAR‐T cell therapy for lung cancer: Potential and perspective
por: Chen, Long, et al.
Publicado: (2022)

Hybrid imaging with [(68)Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer
por: Glemser, P. A., et al.
Publicado: (2022)

Comparison of diagnostic efficacy of (18)F-FDG PET/CT and (68)Ga-DOTANOC PET/CT in ectopic adrenocorticotropic hormone syndrome
por: Zhang, Bing, et al.
Publicado: (2022)

Initial Institutional Experience with 18F-Fluciclovine PET-CT in Biochemical Recurrence of Prostate Cancer
por: Farkas, Amy B., et al.
Publicado: (2021)

Diagnostic accuracy of [(18)F]PSMA-1007 PET/CT in biochemical recurrence of prostate cancer
por: Mingels, Clemens, et al.
Publicado: (2022)

Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer
por: von Eyben, Rie, et al.
Publicado: (2023)

Diagnostic performance of (18)F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer
por: Rahbar, Kambiz, et al.
Publicado: (2018)

(18)F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic review
por: Rais-Bahrami, Soroush, et al.
Publicado: (2021)

Evaluation of Predictors of Biochemical Recurrence in Prostate Cancer Patients, as Detected by (68)Ga-PSMA PET/CT
por: Christensen, Mads T., et al.
Publicado: (2022)

Evaluation of (18)F-PSMA-1007 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy
por: Zhou, Xing, et al.
Publicado: (2021)

Choline PET/CT in recurrent prostate cancer
por: Detti, Beatrice, et al.
Publicado: (2023)

The positivity rate of 68Gallium-PSMA-11 ligand PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer
por: Hoffmann, Manuela A., et al.
Publicado: (2019)

Metabolic syndrome-related prognostic index: Predicting biochemical recurrence and differentiating between cold and hot tumors in prostate cancer
por: Ren, Congzhe, et al.
Publicado: (2023)

Value of machine learning-based transrectal multimodal ultrasound combined with PSA-related indicators in the diagnosis of clinically significant prostate cancer
por: Zhang, Maoliang, et al.
Publicado: (2023)

Benign pancreatic lesion on (18)F-FDG PET-MRI: A case report
por: Xiao, Yuqiang, et al.
Publicado: (2023)

Clinical significance of miR-34a expression in thyroid diseases – an (18)F-FDG PET-CT study
por: Chen, Long, et al.
Publicado: (2017)

One-year experience with (68)Ga-PSMA PET/CT: applications and results in biochemical recurrence of prostate cancer
por: Prado Júnior, Luciano Monteiro, et al.
Publicado: (2018)

Texture Analysis of F-18 Fluciclovine PET/CT to Predict Biochemically Recurrent Prostate Cancer: Initial Results
por: Kang, Hakmook, et al.
Publicado: (2020)

Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy Against Thoracic Malignancies: Challenges and Opportunities
por: Chen, Long, et al.
Publicado: (2022)

Detection efficacy of [(89)Zr]Zr-PSMA-617 PET/CT in [(68)Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer
por: Rosar, Florian, et al.
Publicado: (2023)

Potential value of pre- and post-therapy [68Ga]Ga-DOTA-TATE PET/CT in the prognosis of response to PRRT in disseminated neuroendocrine tumors
por: Opalińska, Marta, et al.
Publicado: (2022)

Early lesion detection with (18)F-DCFPyL PET/CT in 248 patients with biochemically recurrent prostate cancer
por: Wondergem, M., et al.
Publicado: (2019)

A Prospective Study on (18)F-DCFPyL PSMA PET/CT Imaging in Biochemical Recurrence of Prostate Cancer
por: Rousseau, Etienne, et al.
Publicado: (2019)

Advanced Imaging of Biochemical Recurrent Prostate Cancer With PET, MRI, and Radiomics
por: Shaikh, Faiq, et al.
Publicado: (2020)

The value of CT-based energy imaging to discriminate dominant side lesions in primary aldosteronism
por: Huang, Minggang, et al.
Publicado: (2023)

The Role of (18)F-FDG PET/CT in the Management of the Autoimmune Thyroid Diseases
por: Małkowski, Bogdan, et al.
Publicado: (2019)

Clinical application of (18)F-FCH PET/CT in the diagnosis and treatment of hyperparathyroidism
por: Liu, Shuang, et al.
Publicado: (2023)

Outcome of patients with biochemical recurrence of prostate cancer after PSMA PET/CT-directed radiotherapy or surgery without systemic therapy
por: Harsini, Sara, et al.
Publicado: (2023)

Role of PET imaging for biochemical recurrence following primary treatment for prostate cancer
por: Galgano, Samuel J., et al.
Publicado: (2018)

The value of radiomics to predict abnormal bone mass in type 2 diabetes mellitus patients based on CT imaging for paravertebral muscles
por: Qiu, Hui, et al.
Publicado: (2022)

Clinical and biochemical determinants of length of stay, readmission and recurrence in patients admitted with diabetic ketoacidosis
por: Ata, Fateen, et al.
Publicado: (2023)

Histologically Confirmed Testicular Metastasis Revealed by [(89)Zr]Zr-PSMA-617 PET/CT in a Patient with Biochemical Recurrence of Prostate Cancer and Negative Conventional PSMA PET/CT Imaging
por: Rosar, Florian, et al.
Publicado: (2023)

Differential diagnostic value of plain CT scan in adrenal adenoma and non-adenoma: A two-center control study of mean attenuation value, minimum attenuation value, and CT histogram
por: Han, Zhijiang, et al.
Publicado: (2022)

Diagnostic Role of (18)F-FECH-PET/CT Compared with Bone Scan in Evaluating the Prostate Cancer Patients Referring with Biochemical Recurrence
por: Takesh, Mustafa, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_n4kfll9lo62vul5kbf4isbkku4